Ocular


JMP Highlights Two Biotech Stocks to Consider Ahead of Upcoming FDA Decisions: Trevena (TRVN), Ocular (OCUL)

JMP analysts have profiled two biopharmaceutical firms that they believe are set up to do well in the rest of 2018 and beyond. Both companies are …

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) About to Attract a Lot of Investor Attention with New IP Lawsuit; Ocular Therapeutix Inc (OCUL) Gains a Bull

Evercore ISI: Teva throws lawsuit at competitor Lilly; Guggenheim: OCUL’s assets looking at $$$ billions.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts